BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram VideoAccesswire · Sep 23, 2026
BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring ProgressAccesswire · Sep 3, 2026
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)Accesswire · Aug 31, 2026
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure UpdateAccesswire · Aug 13, 2026
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing SignalAccesswire · Aug 12, 2026
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness FormulaAccesswire · Aug 3, 2026BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.